In HAM/TSP patients, CD4+ T-cells show some degree of resistance to anti-proliferative effects from TGF-β signaling, which is known to suppress the expansion of activated T-cells and modulate T-cell differentiation [18,19,20,21]. The gene discussed is TGFB1; the disease is tropical spastic paraparesis.